Cancer Milestones

The ancient physician Hippocrates described the projection of blood vessels from a collection of cells as ‘karkinos’, the Greek word for crab. Today, we know this malignant growth as cancer. Although it remains one of our biggest killers, survival rates for several tumour types have improved dramatically in recent years. These Milestones celebrate two decades of breakthroughs in basic, translational and clinical research which have revolutionised our understanding and management of cancer.

This Milestone is editorially independent, produced with financial support from a third party. About this content.

Co-ordinating editors:

Safia Danovi, Nature Genetics 

Saheli Sadanand, Nature Medicine

Writing and handling editors:

Javier Carmona, Nature Medicine

Megan Cully, Nature Reviews Drug Discovery 

Anna Dart, Nature Reviews Cancer 

Iain Dickson, Nature Reviews Gastroenterology & Hepatology 

Michael Fletcher, Nature Genetics 

Miguel Foronda, Nature Cancer 

Linda Gummlich, BMC Cancer

Ulrike Harjes, Nature Reviews Cancer 

David Killock, Nature Reviews Clinical Oncology 

Linda Koch, Nature Reviews Genetics 

Barbara Marte, Nature 

Diana Romero, Nature Reviews Clinical Oncology 

Sarah Seton-Rogers, Nature Reviews Cancer 

Peter Sidaway, Nature Reviews Clinical Oncology

Ilse Valtierra, Nature Communications 

M. Teresa Villanueva, Nature Reviews Drug Discovery 

Monica Wang, Nature Reviews Nephrology 


David J. Adams, Wellcome Trust Sanger Institute, United Kingdom 

Catherine Alix-Panabières, University of Montpellier, France

René Bernards, Netherlands Cancer Institute, the Netherlands

Trever G. Bivona, University of California, San Francisco, USA

Navdeep S. Chandel, Northwestern University, USA

Ryan B. Corcoran, Dana-Farber Cancer Institute, USA 

Sarah-Jane Dawson, Peter MacCallum Cancer Centre, Australia 

Julian Downward, The Francis Crick Institute, United Kingdom 

Kristian Helin, Memorial Sloan Kettering Cancer Center, USA 

Jakob N. Kather, University Hospital RWTH Aachen and German Cancer Research Center, Germany

Christopher A. Klebanoff, Memorial Sloan Kettering Cancer Center, US

Crystal L. Mackall, Stanford University, USA 

Ignacio Melero, CIMA and Clinica Universidad de Navarra, Spain

Narges Razavian, New York University, USA 

John T. Schiller, National Institutes of Health, USA

Clemens A. Schmitt, Charité – University Medical Center and Max-Delbrück-Center for Molecular Medicine, Germany

Charles Swanton, The Francis Crick Institute and University College London Cancer Institute, United Kingdom 

Giorgio Trinchieri, National Institutes of Health, USA

Laurence Zitvogel, Gustave Roussy Cancer Center, France